Aventis CFC-Free Nasacort HFA Approved
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved Aventis'Nasacort HFA (triamcinolone acetonide) for the treatment of nasal symptoms of seasonal and perennial allergic rhinitis in patients six years of age and older April 7